Evelo Biosciences, Inc.
NASDAQ:EVLO
0.0004 (USD) • At close November 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 47.94 | 68.441 | 68.857 | 77.833 | 147.919 | 38.246 | 15.536 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 54.818 | 0 | 0 |
| Cash and Short Term Investments
| 47.94 | 68.441 | 68.857 | 77.833 | 147.919 | 38.246 | 15.536 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.633 | 2.585 | 2.123 | 3.176 | 3.703 | 0.531 | 0.184 |
| Total Current Assets
| 51.573 | 71.026 | 68.857 | 77.833 | 147.919 | 38.777 | 15.72 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 11.71 | 15.532 | 18.235 | 8.341 | 6.925 | 3.496 | 2.504 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.158 | 1.313 | 3.547 | 4.746 | 5.023 | 1.515 | 0.346 |
| Total Non-Current Assets
| 12.868 | 16.845 | 21.782 | 13.087 | 11.948 | 5.011 | 2.85 |
| Total Assets
| 64.441 | 87.871 | 90.639 | 90.92 | 159.867 | 43.788 | 18.57 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1.764 | 1.601 | 19.833 | 9.743 | 9.235 | 1.411 | 0.637 |
| Short Term Debt
| 2.259 | 1.951 | 1.674 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 7.5 | 13.068 | -2.137 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.872 | 0.742 | 0.463 | 0 | 0 | 2.428 | 1.611 |
| Total Current Liabilities
| 12.395 | 17.362 | 19.833 | 9.743 | 9.235 | 3.839 | 2.248 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 48.879 | 54.342 | 40.037 | 19.634 | 12.305 | 9.966 | 9.931 |
| Deferred Revenue Non-Current
| 7.5 | 7.5 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | -7.5 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.659 | 7.5 | 0.284 | 1.346 | 1.378 | 0.58 | 0.865 |
| Total Non-Current Liabilities
| 57.038 | 61.842 | 40.321 | 20.98 | 13.683 | 10.546 | 10.796 |
| Total Liabilities
| 69.433 | 79.204 | 60.154 | 30.723 | 22.918 | 14.385 | 13.044 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 90.92 | 159.867 | 0.084 | 33.863 |
| Common Stock
| 0.111 | 0.054 | 0.047 | 0.032 | 0.032 | 0.02 | 0.004 |
| Retained Earnings
| -529.222 | -414.695 | -292.519 | -198.853 | -113.381 | -56.411 | -28.341 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -90.92 | -0.018 | -1.429 | -0.595 |
| Other Total Stockholders Equity
| 524.119 | 423.308 | 322.957 | 259.018 | 90.449 | 87.139 | 0.595 |
| Total Shareholders Equity
| -4.992 | 8.667 | 30.485 | 60.197 | 136.949 | 29.403 | 5.526 |
| Total Equity
| -4.992 | 8.667 | 30.485 | 60.197 | 136.949 | 29.403 | 5.526 |
| Total Liabilities & Shareholders Equity
| 64.441 | 87.871 | 90.639 | 90.92 | 159.867 | 43.788 | 18.57 |